These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22231396)

  • 21. Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments.
    Scholl S; Fleischmann M; Schnetzke U; Heidel FH
    Cells; 2020 Nov; 9(11):. PubMed ID: 33212779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FLT3 Inhibitors for Treating Acute Myeloid Leukemia.
    Hassanein M; Almahayni MH; Ahmed SO; Gaballa S; El Fakih R
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):543-549. PubMed ID: 27450971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Development of FLT3 Inhibitors in Acute Myeloid Leukemia.
    Garcia JS; Stone RM
    Hematol Oncol Clin North Am; 2017 Aug; 31(4):663-680. PubMed ID: 28673394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of 4-piperazinyl-2-aminopyrimidine derivatives as dual inhibitors of JAK2 and FLT3.
    Li Y; Ye T; Xu L; Dong Y; Luo Y; Wang C; Han Y; Chen K; Qin M; Liu Y; Zhao Y
    Eur J Med Chem; 2019 Nov; 181():111590. PubMed ID: 31408808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Future of Targeting FLT3 Activation in AML.
    Leick MB; Levis MJ
    Curr Hematol Malig Rep; 2017 Jun; 12(3):153-167. PubMed ID: 28421420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia.
    Fathi AT; Chen YB
    Eur J Haematol; 2017 Apr; 98(4):330-336. PubMed ID: 28000291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma.
    William AD; Lee AC; Blanchard S; Poulsen A; Teo EL; Nagaraj H; Tan E; Chen D; Williams M; Sun ET; Goh KC; Ong WC; Goh SK; Hart S; Jayaraman R; Pasha MK; Ethirajulu K; Wood JM; Dymock BW
    J Med Chem; 2011 Jul; 54(13):4638-58. PubMed ID: 21604762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with
    Yamaura T; Nakatani T; Uda K; Ogura H; Shin W; Kurokawa N; Saito K; Fujikawa N; Date T; Takasaki M; Terada D; Hirai A; Akashi A; Chen F; Adachi Y; Ishikawa Y; Hayakawa F; Hagiwara S; Naoe T; Kiyoi H
    Blood; 2018 Jan; 131(4):426-438. PubMed ID: 29187377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of novel thieno[2,3-d]pyrimidine-based FLT3 inhibitors as anti-leukemic agents.
    Yang JS; Park CH; Lee C; Kim H; Oh C; Choi Y; Kang JS; Yun J; Jeong JH; Kim MH; Han G
    Eur J Med Chem; 2014 Oct; 85():399-407. PubMed ID: 25108079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia.
    Gebru MT; Wang HG
    J Hematol Oncol; 2020 Nov; 13(1):155. PubMed ID: 33213500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in FLT3 inhibitors for acute myeloid leukemia.
    Tong L; Li X; Hu Y; Liu T
    Future Med Chem; 2020 May; 12(10):961-981. PubMed ID: 32314599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-Molecule Fms-like Tyrosine Kinase 3 Inhibitors: An Attractive and Efficient Method for the Treatment of Acute Myeloid Leukemia.
    Zhong Y; Qiu RZ; Sun SL; Zhao C; Fan TY; Chen M; Li NG; Shi ZH
    J Med Chem; 2020 Nov; 63(21):12403-12428. PubMed ID: 32659083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of small molecule Flt3 receptor protein-tyrosine kinase inhibitors in the treatment of Flt3-positive acute myelogenous leukemias.
    Roskoski R
    Pharmacol Res; 2020 May; 155():104725. PubMed ID: 32109580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual FLT3 inhibitors: Against the drug resistance of acute myeloid leukemia in recent decade.
    Yuan T; Qi B; Jiang Z; Dong W; Zhong L; Bai L; Tong R; Yu J; Shi J
    Eur J Med Chem; 2019 Sep; 178():468-483. PubMed ID: 31207462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based design of oxygen-linked macrocyclic kinase inhibitors: discovery of SB1518 and SB1578, potent inhibitors of Janus kinase 2 (JAK2) and Fms-like tyrosine kinase-3 (FLT3).
    Poulsen A; William A; Blanchard S; Lee A; Nagaraj H; Wang H; Teo E; Tan E; Goh KC; Dymock B
    J Comput Aided Mol Des; 2012 Apr; 26(4):437-50. PubMed ID: 22527961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closing in on targeted therapy for acute myeloid leukaemia.
    The Lancet Haematology
    Lancet Haematol; 2019 Jan; 6(1):e1. PubMed ID: 30612709
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
    Naqvi K; Konopleva M; Ravandi F
    Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
    Wu H; Hu C; Wang A; Weisberg EL; Wang W; Chen C; Zhao Z; Yu K; Liu J; Wu J; Nonami A; Wang L; Wang B; Stone RM; Liu S; Griffin JD; Liu J; Liu Q
    Leukemia; 2016 Mar; 30(3):754-7. PubMed ID: 26139428
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia.
    Smith CC; Shah NP
    Am Soc Clin Oncol Educ Book; 2013; ():313-8. PubMed ID: 23714533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of blast clearance on sorafenib in relapsed FLT3-ITD acute myeloid leukemia: evidence of efficacy continues to mount.
    Fesler MJ; Richart JM; Petruska PJ
    Leuk Res; 2010 Oct; 34(10):e268-9. PubMed ID: 20417967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.